ACCESSION: MSBNK-SMB_Measured-HSA015P0316004
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 18
COMMENT: RAW_SPEC {'EL13_pos_3106': {'bp': 287714.0, 'sum': 990096.0}, 'EL01_pos_3106': {'bp': 246158.0, 'sum': 907312.0}, 'EL02_pos_3117': {'bp': 219312.0, 'sum': 810676.0}, 'EL14_pos_3112': {'bp': 200076.0, 'sum': 727516.0}, 'EL05_pos_3118': {'bp': 169441.0, 'sum': 643846.0}, 'EL04_pos_3107': {'bp': 143039.0, 'sum': 493091.0}, 'EL16_pos_3105': {'bp': 133863.0, 'sum': 466699.0}, 'EL03_pos_3214': {'bp': 132658.0, 'sum': 523673.0}, 'EL15_pos_3107': {'bp': 131324.0, 'sum': 439701.0}, 'EL11_pos_3106': {'bp': 113086.0, 'sum': 471984.0}, 'EL24_pos_3125': {'bp': 111918.0, 'sum': 385616.0}, 'EL06_pos_3111': {'bp': 110090.0, 'sum': 426533.0}, 'EL12_pos_3106': {'bp': 104281.0, 'sum': 370137.0}, 'EL07_pos_3105': {'bp': 100196.0, 'sum': 383188.0}, 'EL17_pos_3107': {'bp': 96684.0, 'sum': 322172.0}, 'EL09_pos_3112': {'bp': 87299.0, 'sum': 373610.0}, 'EL08_pos_3105': {'bp': 84528.0, 'sum': 326607.0}, 'EL10_pos_3111': {'bp': 81410.0, 'sum': 326530.0}}
COMMENT: RETENTION_TIME_STDEV 0.027
COMMENT: PRECURSOR_M/Z_RAW 316.211904
COMMENT: PRECURSOR_M/Z_STDEV 0.000069
COMMENT: PRECURSOR_IN_MS1 mz 316.211892; int 84.293; delta(ppm) 1.289953
COMMENT: PROPOSED_CHARGE_STATE +1; mz 317.215170; int 14.991; cor 0.907
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 4.099; C17H25N5O; [M+H]+; delta(ppm) -4.098925
COMMENT: PROPOSED_MF SevenGoldenRules 0.143; C16H29NO5; [M+H]+; delta(ppm) 0.142764
COMMENT: PROPOSED_MF SevenGoldenRules 3.423; C10H30N5O4P; [M+H]+; delta(ppm) 3.423173
COMMENT: PROPOSED_MF MS-FINDER 3.527; C16H29NO5; [M+H]+; delta(ppm) 0.140809
COMMENT: PROPOSED_MF MS-FINDER 2.550; C17H25N5O; [M+H]+; delta(ppm) -4.088661
COMMENT: PROPOSED_MF MS-FINDER 2.497; C10H30N5O4P; [M+H]+; delta(ppm) 3.409390
COMMENT: PROPOSED_MF MS-FINDER 2.409; C9H29N7O3S; [M+H]+; delta(ppm) -2.027987
COMMENT: PROPOSED_MF MS-FINDER 1.958; C17H33NS2; [M+H]+; delta(ppm) -2.607397
COMMENT: PROPOSED_MF SIRIUS5_Sirius 37.275; C16H29NO5; [M+H]+; delta(ppm) 0.140809
COMMENT: PROPOSED_MF SIRIUS5_Sirius 18.619; C17H25N5O; [M+H]+; delta(ppm) -4.088661
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C16H29NO5; [M+H]+; delta(ppm) 0.140809
COMMENT: PROPOSED_MF SIRIUS6_Sirius 67.578; C16H29NO5; [M+H]+; delta(ppm) 0.140809
COMMENT: PROPOSED_MF SIRIUS6_Sirius 49.078; C12H25N7O3; [M+H]+; delta(ppm) 8.633060
COMMENT: PROPOSED_MF SIRIUS6_Sirius 41.286; C17H25N5O; [M+H]+; delta(ppm) -4.088661
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.200; C14H27N4O4; [M+H]+; delta(ppm) 4.386917
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.065; C15H33NO2Si2; [M+H]+; delta(ppm) -168205.794004
COMMENT: PROPOSED_MF SIRIUS6_Sirius 36.644; C9H26FN7O4; [M+H]+; delta(ppm) 5.019441
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.943; C14H26FN5O2; [M+H]+; delta(ppm) -7.702188
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.218; C14H28F3NO3; [M+H]+; delta(ppm) 7.873901
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.444; C19H27N2O2; [M+H]+; delta(ppm) -8.334696
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.089; C8H28N8O3P; [M+H]+; delta(ppm) 7.655526
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H29NO5; [M+H]+; delta(ppm) 0.140809
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.389; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; CCCCCCCCCC(=O)CC(=O)NC(CCO)C(=O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.378; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; CCCCC(CC)CNC(=O)CC(C)OC(=O)CCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.318; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; N=1N=C(OC1C2=CN=CN2C)C3CN(CC3)CC4CCCCC4
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.299; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N=1OC(=NC1C=2C=NC(=CC2)N(C)C)C3N(CCC3)CC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.290; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; CC[C@H](C)[C@](O)([C@H](C)O)C(=O)OC[C@H]1CC[N@+]2([O-])CCC[C@H]12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.766; IYYIBVLOYINRIB-UHFFFAOYSA-N; [M+H]+; (4-hydroxy-2,3,5,7a-tetrahydro-1H-4??-pyrrolizin-7-yl)methyl 2-hydroxy-2-(1-hydroxyethyl)-4-methylpentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.745; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; UNPD166734
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.699; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; Butoctamide hydrogen succinate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.587; LLMHHTKQXBQMLZ-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.539; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; (2S)-4-hydroxy-2-(3-oxododecanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.421; RADBWKDPINYLDT-MWJGYPJQNA-N; [M+H]+; UNPD52456
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.506; KIVDABLXRBLKPT-UHFFFAOYSA-N; [M+H]+; 1-{4-[1-(2-cyanoethyl)-3,5-dimethyl-1H-pyrazol-4-yl]cyclopent-2-en-1-yl}-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.331; MCYRPUWJNNPZAT-UHFFFAOYSA-N; [M+H]+; N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.313; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclohexylmethyl)pyrrolidin-3-yl]-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.249; QVAZDUQDJPUMOS-UHFFFAOYSA-N; [M+H]+; 5-{5-[1-(2,2-dimethylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}-N-methylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.249; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-{5-[1-(2-methylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; MCYRPUWJNNPZAT-UHFFFAOYSA-N; [M+H]+; N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RADBWKDPINYLDT-MWJGYPJQNA-N; [M+H]+; UNPD52456
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.931; IOELOYWUEMCABZ-WBBUPANNNA-N; [M+H]+; UNPD166734
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.895; LLMHHTKQXBQMLZ-UHFFFAOYSA-N; [M+H]+; N-({3,4-dihydroxy-1-[(2-methoxyethoxy)methyl]cyclopentyl}methyl)cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.788; WOIAAVJAGKBTTQ-AWEZNQCLSA-N; [M+H]+; (2S)-4-hydroxy-2-(3-oxododecanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.759; QVAZDUQDJPUMOS-UHFFFAOYSA-N; [M+H]+; 5-{5-[1-(2,2-dimethylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}-N-methylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.673; NQYBLSMJHLCTDP-UHFFFAOYSA-N; [M+H]+; 2-[1-(cyclohexylmethyl)pyrrolidin-3-yl]-5-(1-methyl-1H-imidazol-5-yl)-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.578; KIVDABLXRBLKPT-UHFFFAOYSA-N; [M+H]+; 1-{4-[1-(2-cyanoethyl)-3,5-dimethyl-1H-pyrazol-4-yl]cyclopent-2-en-1-yl}-3-(propan-2-yl)urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.546; CQONVBIGUJWUFE-UHFFFAOYNA-N; [M+H]+; Butoctamide hydrogen succinate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.530; VZGIUZRNOZEULU-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-{5-[1-(2-methylpropyl)pyrrolidin-2-yl]-1,2,4-oxadiazol-3-yl}pyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.559; VCRXMSMANOGRCM-ZDUSSCGKSA-N; [M+H]+; (2S)-2-(dodecanoylamino)butanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.356; CQONVBIGUJWUFE-UHFFFAOYSA-N; [M+H]+; 4-[4-(2-ethylhexylamino)-4-oxobutan-2-yl]oxy-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.036; PCNAKWUTWPAVMZ-UHFFFAOYSA-N; [M+H]+; 2-[carboxymethyl(dodecanoyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; SQTHUAITVREGCH-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-[3-(4-methylpiperazin-1-yl)propyl]-3H-pyrido[2,3-b][1,4]diazepin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.573; MHJDREYXLOFFDT-UHFFFAOYSA-N; [M+H]+; 4-amino-N-[2-(diethylamino)ethyl]-6,7-dimethylcinnoline-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.565; BSQIJYAFXZDYBP-UHFFFAOYSA-N; [M+H]+; 7-methyl-2-(4-piperidin-1-ylpiperidin-1-yl)-5H-pyrrolo[2,3-d]pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.767; PCNAKWUTWPAVMZ; [M+H]+; Lauroyliminodiacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.504; IJMMECIIPUTJIH; [M+H]+; Boc-achpa
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.226; CQONVBIGUJWUFE; [M+H]+; Listomin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.405; WOIAAVJAGKBTTQ; [M+H]+; N-(3-oxododecanoyl)-L-homoserine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -334.106; LLMHHTKQXBQMLZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.790; IOELOYWUEMCABZ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -373.812; RADBWKDPINYLDT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.187; PCNAKWUTWPAVMZ; [M+H]+; Lauroyliminodiacetic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C16H30N1O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 5.037
MS$FOCUSED_ION: PRECURSOR_M/Z 316.211894
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-014i-5559000000-66f718511030f7ff218e
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0181112 24.3468 55.018819 1.6540 4.33 0.8471 16 f{C3H3O1}/4.91ppm,p-C13H27N1O4
  57.0701224 58.1709 57.070839 1.3142 10.45 0.8989 18 f{C4H9}/4.31ppm,p-C12H21N1O5
  59.0493998 29.7291 59.050124 0.8976 8.60 0.6923 14 f{C3H7O1}/4.38ppm,p-C13H23N1O4
  81.0699436 56.8431 81.070670 1.3815 6.87 0.9142 17 f{C6H9}/0.83ppm,p-C10H21N1O5
  84.0808056 118.6905 84.081521 0.7731 13.71 0.8844 18 f{C5H10N1}/0.36ppm,p-C11H20O5
  85.0648369 114.2306 85.065548 1.0110 16.21 0.8284 17 f{C5H9O1}/0.54ppm,p-C11H21N1O4
  87.0441672 33.2438 87.044869 1.0340 8.13 0.8242 14 f{C4H7O2}/1.28ppm,p-C12H23N1O3
  99.0440819 234.4660 99.044703 0.5957 22.48 0.9463 18 f{C5H7O2}/0.26ppm,p-C11H23N1O3
  102.0913660 101.4420 102.091959 0.9697 11.94 0.9340 18 f{C5H12N1O1}/0.25ppm,p-C11H18O4
  115.0389657 138.9937 115.039449 0.9127 16.60 0.9732 18 f{C5H7O3}/-0.04ppm,p-C11H23N1O2
  123.1169753 36.1110 123.117384 1.1940 8.37 0.6078 18 f{C9H15}/1.21ppm,p-C7H15N1O5
  126.0549850 26.2884 126.055364 1.5945 7.05 0.7582 14 f{C6H8N1O2}/0.24ppm,p-C10H22O3
  159.0652131 299.7220 159.065539 0.4464 23.63 0.9690 18 f{C7H11O4}/0.18ppm,p-C9H19N1O1
  176.0917438 130.9148 176.092119 1.0960 15.86 0.9257 18 f{C7H14N1O4}/0.05ppm,p-C9H16O1
  216.1230483 631.1595 216.123458 0.2822 34.72 0.9752 18 f{C10H18N1O4}/0.06ppm,p-C6H12O1
  217.1266684 55.5085 217.127075 1.1053 6.48 0.8813 14 ?
  316.2118261 999.0000 316.212246 0.8602 0.00 1.0000 18 f{C16H30N1O5}/-0.07ppm,p
  317.2153044 149.5867 317.215725 0.8701 14.52 0.9412 16 ?
PK$NUM_PEAK: 18
PK$PEAK: m/z int. rel.int.
  55.018111 24.35 24
  57.070122 58.17 58
  59.049400 29.73 29
  81.069944 56.84 56
  84.080806 118.69 118
  85.064837 114.23 114
  87.044167 33.24 33
  99.044082 234.47 234
  102.091366 101.44 101
  115.038966 138.99 138
  123.116975 36.11 36
  126.054985 26.29 26
  159.065213 299.72 299
  176.091744 130.91 130
  216.123048 631.16 631
  217.126668 55.51 55
  316.211826 999.00 999
  317.215304 149.59 149
//
